Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1130-1137
Published online before print April 22, 2004, doi: 10.1161/01.ATV.0000129537.72553.73
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/6/1130    most recent
01.ATV.0000129537.72553.73v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henke, P. K.
Right arrow Articles by Wakefield, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henke, P. K.
Right arrow Articles by Wakefield, T. W.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1130.)
© 2004 American Heart Association, Inc.


Thrombosis

Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model

Peter K. Henke; Andrea Varga; Sumit De; C. Barry Deatrick; Jonathon Eliason; Douglas A. Arenberg; Pasu Sukheepod; Porama Thanaporn; Steven L. Kunkel; Gilbert R. Upchurch, Jr; Thomas W. Wakefield

From the Section of Vascular Surgery, Jobst Vascular Research Laboratory, Department of Surgery (P.K.H., A.V., S.D., C.B.D., J.E., P.S., P.T., G.R.U., T.W.W.), the Division of Pulmonary Medicine, Department of Medicine (D.A.A.), and the Department of Pathology (S.L.K.), University of Michigan Medical School, Ann Arbor, Mich.

Correspondence to Dr Peter K. Henke, 1500 East Medical Center Drive, Room 2210 Taubman Health Care Center, Ann Arbor, MI 48109-0329. E-mail henke{at}umich.edu

Objective— To determine the role of CXCR2, the receptor for cysteine-X-cysteine (CXC) chemokines, and its primary effector cell, the neutrophil (PMN), on deep venous thrombosis (DVT) resolution.

Methods and Results— DVT in BALB/c, anti-CXCR2 antibody-treated, and BALB/c CXCR2–/– mice were created by infrarenal inferior vena cava (IVC) ligation and the thrombus harvested at various time points over 21 days. The CXCR2–/– mice had significantly larger thrombi at early time points (days 2 to 8), and significantly decreased intrathrombus PMNs, monocytes, and neovascularization as compared with controls. Thrombus KC/CXCL1 was significantly higher at 2 days in CXCR2–/– thrombi as measured by enzyme-linked immunosorbent assay. Fibrin content was significantly higher, with less uPA gene expression at 4 days in CXCR2–/– thrombi. Late fibrotic maturation of the thrombus was delayed in the CXCR2–/– mice, with significantly decreased 8 day MMP-2 activity, whereas MMP-9 activity was elevated as compared with controls. Similar impairment in DVT resolution was found at 8 days with anti-CXCR2 inhibition. However, systemic neutropenia, unlike CXCR2 deletion, did not increase the thrombus size as compared with controls.

Conclusions— Normal DVT resolution involves CXCR2-mediated neovascularization, collagen turnover, and fibrinolysis, and it is probably primarily monocyte-dependent.

The role of CXCR2 activity on DVT resolution was determined. Thrombi in CXCR2–/– or anti-CXCR2–treated mice had fewer PMN and monocytes and impaired early DVT resolution. PMN depletion did not affect DVT resolution to the same degree, suggesting monocytic CXCR2-mediated activity is more important for DVT resolution.


Key Words: inflammation • chemokines • neutrophils • angiogenesis




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. J. Tracz, J. P. Juncos, J. P. Grande, A. J. Croatt, A. W. Ackerman, Z. S. Katusic, and K. A. Nath
Induction of Heme Oxygenase-1 is a Beneficial Response in a Murine Model of Venous Thrombosis
Am. J. Pathol., December 1, 2008; 173(6): 1882 - 1890.
[Abstract] [Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
P. Henke
Commentary on "The Issue of Spontaneous Arteriovenous Fistulae after Superficial Thrombophlebitis, Endovenous Ablations, and Deep Vein Thrombosis: An Unusual but Predictable Finding"
Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2006; 18(3): 251 - 252.
[PDF]


Home page
J. Immunol.Home page
P. K. Henke, C. G. Pearce, D. M. Moaveni, A. J. Moore, E. M. Lynch, C. Longo, M. Varma, N. A. Dewyer, K. B. Deatrick, G. R. Upchurch Jr, et al.
Targeted Deletion of CCR2 Impairs Deep Vein Thombosis Resolution in a Mouse Model.
J. Immunol., September 1, 2006; 177(5): 3388 - 3397.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Eliason, K. K. Hannawa, G. Ailawadi, I. Sinha, J. W. Ford, M. P. Deogracias, K. J. Roelofs, D. T. Woodrum, T. L. Ennis, P. K. Henke, et al.
Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation
Circulation, July 12, 2005; 112(2): 232 - 240.
[Abstract] [Full Text] [PDF]